Evidence map›Paper›PMID 34677386›Full record

ArticleMetabolites2021

Urinary Metabolome Analyses of Patients with Acute Kidney Injury Using Capillary Electrophoresis-Mass Spectrometry.

Rintaro Saito, Akiyoshi Hirayama, Arisa Akiba, Yushi Kamei, Yuyu Kato, Satsuki Ikeda, Brian Kwan, Minya Pu, Loki Natarajan, Hibiki Shinjo and 4 more

Open access · goldAbstract read
In one paragraph

Article in Metabolites, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. CKD Urine Metabolomics: Modern Concepts and Approaches.Pathophysiology : the official journal of the International Society for Pathophysiology · 2023
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Rintaro SaitoInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.ORCID 0000-0001-9084-8045
Akiyoshi HirayamaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.ORCID 0000-0002-0440-6820
Arisa AkibaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.
Yushi KameiInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.
Yuyu KatoInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.
Satsuki IkedaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.
Brian KwanDivision of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0002-5180-9219
Minya PuDivision of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093, USA.
Loki NatarajanDivision of Biostatistics and Bioinformatics, Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-5719-828X
Hibiki ShinjoDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Shin'ichi AkiyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Masaru TomitaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.
Tomoyoshi SogaInstitute for Advanced Biosciences, Keio University, Tsuruoka 997-0052, Japan.ORCID 0000-0001-9502-2509
Shoichi MaruyamaDepartment of Nephrology, Nagoya University Graduate School of Medicine, Nagoya 466-8560, Japan.
Keio University · JPNagoya University · JPUniversity of California San Diego · US

Funding

Developing and validating prognostic metabolomic signatures of diabetic kidney diseaseR01DK110541 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI NATARAJAN, LOKI · 2017 to 2020
$1.3M
NIDDK NIH HHS 1R01DK110541-01NIDDK NIH HHS R01 DK110541
6 · The paper itself

Abstract

Acute kidney injury (AKI) is defined as a rapid decline in kidney function. The associated syndromes may lead to increased morbidity and mortality, but its early detection remains difficult. Using capillary electrophoresis time-of-flight mass spectrometry (CE-TOFMS), we analyzed the urinary metabolomic profile of patients admitted to the intensive care unit (ICU) after invasive surgery. Urine samples were collected at six time points: before surgery, at ICU admission and 6, 12, 24 and 48 h after. First, urine samples from 61 initial patients (non-AKI: 23, mild AKI: 24, severe AKI: 14) were measured, followed by the measurement of urine samples from 60 additional patients (non-AKI: 40, mild AKI: 20). Glycine and ethanolamine were decreased in patients with AKI compared with non-AKI patients at 6-24 h in the two groups. The linear statistical model constructed at each time point by machine learning achieved the best performance at 24 h (median AUC, area under the curve: 89%, cross-validated) for the 1st group. When cross-validated between the two groups, the AUC showed the best value of 70% at 12 h. These results identified metabolites and time points that show patterns specific to subjects who develop AKI, paving the way for the development of better biomarkers.

Indexed as

AKIbiomarkercapillary electrophoresis-mass spectrometry (CE-MS)urine

Identifiers

PMID34677386
PMCPMC8540909
OpenAlexW3204463717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.